JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
EBS - Emergent Biosolutions Inc.
USD | NYSE | Healthcare
Summary
Summary EBS Stock
Financials
Financials EBS Stock
Loading...
Loading...
Income Statement
Income Statement EBS Stock
Balance Sheet
Balance Sheet EBS Stock
Cash Flow Statement
Cash Flow Statement EBS Stock
Loading...
Loading...
EBS Financials - Emergent Biosolutions Income & Cash Flow | Ledgeburg
Home
Stocks
Emergent Biosolutions Inc. (EBS)
Financials
Financials of EBS
Loading...
Loading...
Loading...
Loading...
Revenue
$742.9M
Operating Income
$100.1M
Net Income
$52.6M
Share Count (Basic)
53.5M
Operating Cash Flow
$170.6M
Free Cash Flow
$156.8M
Cash And Short-Term Equivalents
$205.4M
Total Debt
$572.1M
Annual
Quarterly
Revenue $USD
0
500M
1B
1.5B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-800M
-600M
-400M
-200M
0
200M
Annual
Quarterly
Margins
Gross
Operating
Net
-50%
0%
50%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-50M
0
50M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-40%
-20%
0%
20%
40%
60%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26